Sun Pharm Inds Inc Company Profile

✉ Email this page to a colleague

SUN PHARM INDS INC has ninety-four approved drugs.

There are three US patents protecting SUN PHARM INDS INC drugs. There are two tentative approvals on SUN PHARM INDS INC drugs.

There are five patent family members on SUN PHARM INDS INC drugs in three countries and one hundred and twenty-nine supplementary protection certificates in sixteen countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Inc	RISPERIDONE	risperidone	TABLET;ORAL	078036-006	Mar 10, 2014		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Inds Inc	AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride	TABLET;ORAL	089399-001	Jul 14, 1987	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Inds Inc	INDOMETHACIN	indomethacin	CAPSULE;ORAL	091401-001	Mar 28, 2013		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Sun Pharm Inds Inc	BACLOFEN	baclofen	TABLET;ORAL	077862-001	Aug 14, 2006		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-005	Aug 15, 2014	8,952,064	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-001	May 25, 2012	9,089,534	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-004	May 25, 2012	9,078,925	⤷ Try a Trial
Sun Pharm Inds Inc	ABSORICA	isotretinoin	CAPSULE;ORAL	021951-004	May 25, 2012	8,952,064	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-01-07
➤ Subscribe	Capsules	35 mg	➤ Subscribe	2015-11-25
➤ Subscribe	Capsules	30 mg and 40 mg	➤ Subscribe	2012-12-31
➤ Subscribe	Capsules	20 mg	➤ Subscribe	2013-06-19
➤ Subscribe	Capsules	25 mg	➤ Subscribe	2016-05-16

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
European Patent Office	3346996	⤷ Try a Trial
Japan	2018530535	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2023281441	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2017042835	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2217577	LUC00103	Luxembourg	⤷ Try a Trial	PRODUCT NAME: DUZALLO - ALLOPURINOL/LESINURAD OU UN/DES SEL(S) PHARMACEUTIQUEMENT ACCEPTABLE(S) DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/18/1300 20180827
1532149	PA2012022	Lithuania	⤷ Try a Trial	PRODUCT NAME: LINAGLIPTINUM + METFORMINI HYDROCHLORIDUM; REGISTRATION NO/DATE: EU/1/12/780/001 - EU/1/12/780/034 20120720
1506211	SPC/GB14/050	United Kingdom	⤷ Try a Trial	PRODUCT NAME: A COMBINATION OF DAPAGLIFLOZIN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METFORMIN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/13/900 20140121
2435024	301102	Netherlands	⤷ Try a Trial	PRODUCT NAME: COMBINATIE VAN FORMOTEROL (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN), GLYCOPYRROLAAT (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN) EN BUDESONIDE (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN); REGISTRATION NO/DATE: EU/1/20/1498 20201210
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.